Asset
ABBV-467
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT04178902 | phase1 | terminated | 2020-05-19 | 2021-04-16 | AbbVie | A Study of the Safety and Tolerability of ABBV-467 in Adult Participants With Relapsed/Refractory (R/R) Multiple Myeloma |
FDA applications (0)
This company has no applications containing this asset.